Related Experiment Videos
Cerebral Venous Thrombosis
Valérie Biousse1, Frank Tong, Nancy J. Newman
1Neuro-ophthalmology Unit, Emory Eye Center, 1365-B Clifton Road, Atlanta, GA 30322, USA. vbiouss@emory.edu
Insights
Cerebral venous thrombosis (CVT) presents diagnostic and therapeutic challenges. Early anticoagulation and potential thrombolysis offer hope for recovery, even in severe neurological deficits.
Area of Science:
- Neurology
- Vascular Medicine
Background:
- Cerebral venous thrombosis (CVT) is a complex neurological condition with diverse presentations and unpredictable outcomes.
- Effective diagnosis and management of CVT remain challenging due to its variability.
Purpose of the Study:
- To outline current diagnostic and therapeutic strategies for cerebral venous thrombosis.
- To emphasize the potential for recovery with timely intervention.
Main Methods:
- Review of existing literature on CVT diagnosis and treatment.
- Discussion of symptomatic, antithrombotic, and etiological treatments.
- Exploration of advanced interventions like thrombolysis and mechanical thrombectomy.
Main Results:
- Heparin is the primary treatment, with recent data supporting its safety even in hemorrhagic cases.
- Local thrombolysis is beneficial for patients with worsening symptoms despite anticoagulation.
- Surgical interventions like ventricular drainage and decompressive craniotomy are reserved for specific complications.
Conclusions:
- Despite challenges, CVT management can lead to significant neurological recovery.
- Aggressive treatment, including anticoagulation and thrombolysis, is warranted even in severe cases.
- Multifaceted treatment approaches are crucial for optimizing patient outcomes in CVT.
Abstract:
Because of its wide range of presentations, its highly variable mode of onset, its numerous causes, and its unpredictable outcome, cerebral venous thrombosis (CVT) remains a diagnostic and therapeutic challenge. Treatment of CVT consists primarily of symptomatic treatment of seizures and intracranial hypertension, antithrombotics, and etiologic treatment whenever possible. Heparin remains the first line of treatment for CVT; although its systematic use remains debated, recent studies have confirmed its safety even in patients with large hemorrhagic infarctions. The addition of local thrombolysis is indicated for patients with clinical worsening related to extension of the venous thrombosis, despite adequate anticoagulation and optimal symptomatic and etiologic treatment. In contrast to arterial stroke, complete recovery of prolonged or severe neurologic deficit is possible, justifying initiation of anticoagulation and eventually thrombolysis, even when the clinical situation seems desperate. New techniques using mechanical devices disrupting the clot may be used in addition to thrombolysis in rare cases. Ventricular drainage is indicated in cases of cerebellar infarction or deep venous thrombosis associated with hydrocephalus. Decompressive craniotomy may be performed acutely in patients with untractable intracranial hypertension and herniation.